Arcturus Therapeutics
ARCT
ARCT
42 hedge funds and large institutions have $34.2M invested in Arcturus Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 43 → 42 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
21% less capital invested
Capital invested by funds: $43M → $34.2M (-$8.85M)
Holders
42
Holding in Top 10
1
Calls
$1.14M
Puts
$555K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$1.07M | |
| 3 | +$546K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$532K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$300K |
Top Sellers
| 1 | -$5.05M | |
| 2 | -$954K | |
| 3 | -$513K | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$315K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$147K |